Canthin-6-one 9-O-beta-glucopyranosideas has already been reported for unique properties to stabilize human red blood cell membrane and with no known cytotoxic effect; it has been proposed as a key NF-κB inhibitor in cancer cell line45. Here, NFKB1 is linked to cancer.